publication date: Dec. 18, 2010

In this issue: 

Experts Raise Questions About Influential Swedish Trial Of Mammography Screening.

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

Data-Dredging? Don’t Try It, FDA Says.

Download (PDF 1.5MB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.